HARNESSING THE UNTAPPED POTENTIAL OF THE INNATE IMMUNE SYSTEM FOR ONCOLOGY Q3 2023 Financial Results & Operational Progress NASDAQ: AFMD November 14, 2023 Forward-Looking Statements / Cautionary Note 2 This presentation and the accompanying oral commentary contain "forward-looking" statements that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this presentation and the accompanying oral commentary, including statements regarding our future ...